Literature DB >> 15947484

Stat5a is essential for the proliferation and survival of murine mast cells.

Kei Ikeda1, Hiroshi Nakajima, Kotaro Suzuki, Norihiko Watanabe, Shin-ichiro Kagami, Itsuo Iwamoto.   

Abstract

The regulatory role of signal transducer and activator of transcription (Stat) 5a in the proliferation and survival of mast cells was determined using Stat5a-deficient (Stat5a(-/-)) mice. First, although the mast cells in Stat5a(-/-) mice were morphologically indistinguishable from those in wild-type (WT) mice, the number of peritoneal mast cells was significantly decreased in Stat5a(-/-) mice as compared with that in WT mice. Furthermore, the interleukin-3 (IL-3)-dependent development of bone marrow-derived mast cells (BMMCs) was markedly decreased in Stat5a(-/-) mice. Second, IL-3-induced but not stem cell factor (SCF)-induced proliferation of BMMCs was significantly diminished in Stat5a(-/-) mice as compared with that in WT mice. Moreover, survival rates of both peritoneal mast cells and BMMCs were significantly decreased with increased apoptotic cells in Stat5a(-/-) mice as compared with those in WT mice. Finally, mRNA of Bcl-x(L) was induced after IL-3 stimulation in WT BMMCs but not in Stat5a(-/-) BMMCs, which may account for the accelerated apoptosis in Stat5a(-/-) mast cells. These results indicate that Stat5a plays an important role in mast cell development, proliferation, and survival. Copyright 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15947484     DOI: 10.1159/000085431

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  9 in total

Review 1.  Mast cell homeostasis and the JAK-STAT pathway.

Authors:  J K Morales; Y T Falanga; A Depcrynski; J Fernando; J J Ryan
Journal:  Genes Immun       Date:  2010-06-10       Impact factor: 2.676

2.  Novel mechanism for Fc{epsilon}RI-mediated signal transducer and activator of transcription 5 (STAT5) tyrosine phosphorylation and the selective influence of STAT5B over mast cell cytokine production.

Authors:  Nicholas A Pullen; Brian O Barnstein; Yves T Falanga; Zhengqi Wang; Ryo Suzuki; Tenchee D Lama Tamang; Michele C Khurana; Emily A Harry; Petr Draber; Kevin D Bunting; Kazuya Mizuno; Bridget S Wilson; John J Ryan
Journal:  J Biol Chem       Date:  2011-11-30       Impact factor: 5.157

3.  Oncogenic Kit controls neoplastic mast cell growth through a Stat5/PI3-kinase signaling cascade.

Authors:  Noria Harir; Cédric Boudot; Katrin Friedbichler; Karoline Sonneck; Rudin Kondo; Séverine Martin-Lannerée; Lukas Kenner; Marc Kerenyi; Saliha Yahiaoui; Valérie Gouilleux-Gruart; Jean Gondry; Laurence Bénit; Isabelle Dusanter-Fourt; Kaïss Lassoued; Peter Valent; Richard Moriggl; Fabrice Gouilleux
Journal:  Blood       Date:  2008-06-25       Impact factor: 22.113

4.  Expression of activated STAT5 in neoplastic mast cells in systemic mastocytosis: subcellular distribution and role of the transforming oncoprotein KIT D816V.

Authors:  Christian Baumgartner; Sabine Cerny-Reiterer; Karoline Sonneck; Matthias Mayerhofer; Karoline V Gleixner; Richard Fritz; Marc Kerenyi; Cedric Boudot; Fabrice Gouilleux; Jan-Wilhelm Kornfeld; Christian Sillaber; Richard Moriggl; Peter Valent
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

5.  Interleukin-9 (IL-9) and NPM-ALK each generate mast cell hyperplasia as single 'hit' and cooperate in producing a mastocytosis-like disease in mice.

Authors:  Hartmut Merz; Christian Kaehler; Kai P Hoefig; Biggi Branke; Wolfgang Uckert; Roger Nadrowitz; Sabine Cerny-Reiterer; Harald Herrmann; Alfred C Feller; Peter Valent
Journal:  Oncotarget       Date:  2010-06

6.  The Fyn-STAT5 Pathway: A New Frontier in IgE- and IgG-Mediated Mast Cell Signaling.

Authors:  Nicholas A Pullen; Yves T Falanga; Johanna K Morales; John J Ryan
Journal:  Front Immunol       Date:  2012-05-11       Impact factor: 7.561

7.  Stat5B is required for IgE-Mediated mast cell function in vitro and in vivo.

Authors:  Kasalina N Kiwanuka; E Motunrayo Kolawole; Jamie Josephine Avila Mcleod; Bianca Baker; Patrick A Paez; Matthew P Zellner; Tamara T Haque; Anuya Paranjape; Kaitlyn Jackson; Sydney A Kee; Jordan Dailey; Rebecca K Martin; John J Ryan
Journal:  Cell Immunol       Date:  2021-03-18       Impact factor: 4.178

8.  Effects of somatic alterations at pathway level are more mechanism-explanatory and clinically applicable to quantity of liver metastases of colorectal cancer.

Authors:  Zhong-Guo Zhang; Fei Ma; Shuang Zhao; Xiaoyu Yang; Fang Liu; Chenghai Xue; Liren Liu; Jin Gu; Haozhe Piao
Journal:  Cancer Med       Date:  2019-06-20       Impact factor: 4.452

Review 9.  Controlling Mast Cell Activation and Homeostasis: Work Influenced by Bill Paul That Continues Today.

Authors:  Heather L Caslin; Kasalina N Kiwanuka; Tamara T Haque; Marcela T Taruselli; H Patrick MacKnight; Anuya Paranjape; John J Ryan
Journal:  Front Immunol       Date:  2018-04-26       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.